Egfr-mutated Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Egfr-mutated Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC [Phase 3]
A Phase 3 trial is investigating whether adding glutamine and the probiotic Lactobacillus reuteri can prevent diarrhea associated with EGFR-…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of necitumumab, trastuzumab, and osimertinib for refractory EGFR-mutated stage IV…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas) [Phase 3]
Phase 3 trial of SBRT in newly diagnosed stage IV EGFR-mutated non-small cell lung cancer was terminated.